Cargando…
Circulating Complement C1q as a Novel Biomarker is Associated with the Occurrence and Development of COPD
PURPOSE: Increasing evidence has shown that the immune response interacts with the chronic inflammatory response and gives rise to the occurrence and development of COPD. Complement component 1q (C1q), as a subcomponent of the C1 complex, could be involved in innate and adaptive immunity. Our study...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883408/ https://www.ncbi.nlm.nih.gov/pubmed/35237032 http://dx.doi.org/10.2147/COPD.S347607 |